semaglutide medvi vs. Tirzepatide: Launches Physician-Led Program to Help Patients Choose the Right GLP-1 MEDVi - Personalized Telehealth Care
Description
Indias drug regulator steps up action against unauthorised sale and promotion of GLP-1 weight-loss drugs, warning of health risks and tightening inspections across pharmacies and online platforms.
The @LaskerFDN 2024 Clinical Medical Research Award goes to GLP-1 scientists: Joel Habener, Svetlana Mojsov and @lotte_bjerre Perspective @NEJM by @DanielJDrucker
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been pivotal for obesity treatment, achieving 1525 % weight loss over 1224 months, but questions remain about the potential influence of concomitant losses in muscle mass
Weight loss (WL) is slightly greater in people who experience GI AEs than those who do not
